Sonepcizumab
Product Specifications
CAS Number
1031360-18-5
Target
LPL Receptor
Related Pathways
GPCR/G Protein
Purity
0.989
Bioactivity
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Wyb3839-100gEcoli 100 µg (E. coli)
Recombinant Aspergillus Flavus Cell wall glucanase/allergen F16-like Protein (aa 30-341) [His]
Sign In for Pricing
View Details MBS1375445-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus Tryptophan synthase beta chain (trpB)
Sign In for Pricing
View Details MBS1375445-02 0.02 mg (Yeast)
Recombinant Bacillus cereus Tryptophan synthase beta chain (trpB)
Sign In for Pricing
View Details MBS1375445-03 0.1 mg (E-Coli)
Recombinant Bacillus cereus Tryptophan synthase beta chain (trpB)
Sign In for Pricing
View Details MBS1375445-04 0.1 mg (Yeast)
Recombinant Bacillus cereus Tryptophan synthase beta chain (trpB)
Sign In for Pricing
View Details